The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...
A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...
Serina Therapeutics (SER) announced the closing of the second $5M tranche of its previously announced $10M equity financing with strategic ...
Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.
DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance certification LONDON, Jan. 29, 2025 /PRNewswire/ ...